◆ 会议时间：2023年9月28日至10月1日
◆ 会议地点：土耳其 伊斯坦布尔

◆ 会议简介：

2023年第24届欧洲妇科肿瘤学大会(ESGO2023)将于2023年9月28日至10月1日在土耳其伊斯坦布尔举行，会议由欧洲妇科肿瘤学会(ESGO)主办。ESGO年会/大会是欧洲规模最大的妇科肿瘤学会议，预计有来自世界各地的2800余名专业人士与会。ESGO大会将是一个独特的教育体验，与会者将从超过70个由世界专家主持的涵盖妇科肿瘤学主要议题的科学会议中受益，会议将使用包括全体会议、最佳口头和海报会议等多种形式。ESGO2022将为与会者提供一个学习和讨论妇科癌症研究、治疗和护理方面的最新医学和科学进展，以及与来自世界各地的专家和同行建立联系的机会。

欧洲妇科肿瘤学会（ESGO）成立于1983年，是欧洲领先的妇科癌症研究组织，由来自欧洲和世界各地的3400多名参与妇科癌症治疗、护理、研究的专业人员组成；ESGO致力于通过预防、卓越宣的护理，高质量的研究和教育，提高欧洲妇科（生殖器官和乳腺）癌症患者的健康和福祉。ESGO的愿景是：为欧洲所有妇科癌症患者提供最佳的预防和护理（未经许可禁止复制摘录转载本站任何内容-领域国际医学会议网(lingyuint.com)

ESGO 2023 - 24th European Congress on Gynaecological Oncology

Date: September 28-October 1, 2023
Location: Istanbul, Turkey

Organized by: European Society of Gynaecological Oncology (ESGO)

摘要征文投稿：

点此提交摘要>>>Submit Abstract>>>

Download the Abstract Submission Guidelines

Abstract Topics

1. Cervical cancer
2. Diagnostics
3. Endometrial cancer
4. Fertility/Pregnancy
5. Miscellaneous
6. Ovarian cancer
7. Palliative care
8. Pathology
9. Prevention of gynaecologic cancer
10. Quality of life after treatment
11. Translational research/biomarkers
12. Trophoblastic diseases
13. Vaginal and vulvar cancer
14. Organization of gynaecological cancer care
15. Trial in progress

Instructions for authors of abstract

• Abstracts can only be submitted via the online form, abstracts submitted by fax or email will not be accepted.
• Abstracts must be submitted in English, using UK English spelling.
• The presenting author of an accepted abstract must register and attend the congress.
• The number of submissions is limited to 3 per presenting author.
• The number of authors is limited to 20 per abstract.
• Provide a short specific title indicating the scientific content of the abstract. The background and goals of the study should appear clearly to the reader. The methods need to outline patient group, methods applied, statistical considerations, if applicable. Results must contain data (except for Late Breaking abstracts [LBA]- see below), and the conclusion should be clearly expressed. The following structure will be required:
  • Introduction/Background*
  • Methodology
  • Results*
  • Conclusion*
  • Disclosures* (online recording via the submission form)

*mandatory fields

• The title may not exceed 30 words. The abstract text may not be longer than 300 words (excluding title, authors and disclosures).
• All abbreviations must be defined the first time they appear in the text (but do not define in the title).
• Tables, charts and other graphics (for all in total maximum 1) are permitted and must be in high resolution JPG format.
• Authors should indicate their presentation type preference:
  • Oral presentation preferred
  • Paper poster presentation
  • E-poster only
  • Video presentation
  • Oral presentation in the Young investigator session (only for authors up to 40 years)
  • Place holder for LBA
• The Programme committee reserves the right to decide on the final allocation and presentation method.
• Disclosure of potential conflict of interest (e.g., grant support, consultancy, membership on advisory councils, speaker’s bureau) by all authors and source of funding are mandatory. The submitting author is responsible for collecting a Conflict of interest form for all co-authors. All disclosures should be listed within the last 3 years. A COI template is available here.
• Abstracts submitted via commercial entities will be considered. However, these abstracts should report results from collaborative research conducted by independent (non-commercial) investigators. Investigators, as contributing authors who are employees of commercial entities will only be accepted if independent (academic, clinical and/or scientific) investigators are included as authors. The presenting author should not be an employee of the company.
• Systematic review/meta-analysis abstracts are acceptable.
• Trials in progress (TiP) can be accepted as posters/e-posters but will not be accepted as oral presentations. These should not previously have been presented as TIP at an ESGO congress. TiP abstracts have a separate category/topic.
• Encore abstracts (previously presented at a recent international meeting) can be accepted; however, they should be modified and include some new data if possible.
• If several abstracts are based on similar analyses of the same database and one of them is selected for oral presentation, the authors might be asked to combine some/all data into one presentation.
• Case reports for single cases will not be accepted unless they contain substantial translational work.
• Late Breaking Abstracts (LBA) are generally reserved for newly emerging data that is not available at the time of abstract submission. These could be for initial presentation of results, or significant secondary endpoint analyses. A placeholder LBA must be submitted containing the preliminary title, background, methods and type of results that will be presented. LBA will generally not be accepted at a later date unless a shell abstract has been submitted.

注册费：

Registration fee includes:

• Admission to scientific sessions (except for Meet the Expert session and Workshops)
• Entrance to poster/e-poster and exhibition areas (Sept 28-30, 2023)
• An invitation to the welcome drink on Sept 28, 2023
• Coffee and lunch breaks
• Congress materials (badge, etc.)
• Access to the congress recorded sessions for 3 months, until Dec 31, 2023.

* In order to benefit from the ESGO Membership reduced rate, membership for 2023 must be valid and paid before September 30, 2023.

Please note that if you have just registered and paid for ESGO membership you will not be able to register as ESGO member for the ESGO 2023 congress immediately. Please do not register for the congress earlier than 5 working days after paying the membership fee.

** Includes all physicians undergoing training in gynaecological oncology (or related specialties) in a temporary position. An official letter from the institution (PDF format) originally stamped and signed by the head of the department and confirming this status, must accompany the registration process.

*** Registration fees are based on country tiers as per the World Bank classification.

**** Industry registration - fee for company representatives (other fees are ONLY for health care professionals, clinicians, nurses).

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。